Previous Article | Next Article 
Journal of Virology, July 2001, p. 6375-6383, Vol. 75, No. 14
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.14.6375-6383.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Many Nonmammalian Cells Exhibit Postentry Blocks to
Transduction by Gammaretroviruses Pseudotyped with Various Viral
Envelopes, Including Vesicular Stomatitis Virus G
Glycoprotein
Clarissa
Dirks1,2 and
A. Dusty
Miller2,3,*
Molecular and Cellular Biology
Program1 and Division of Human
Biology,2 Fred Hutchinson Cancer Research
Center, Seattle, Washington 98109-1024, and Department of
Pathology, University of Washington, Seattle, Washington
981953
Received 27 December 2000/Accepted 13 April 2001
 |
ABSTRACT |
Previous studies have suggested that Moloney murine leukemia virus
(MoMLV)-based vectors pseudotyped with the vesicular stomatitis virus G
glycoprotein (VSV-G) have extensive ability to transduce nonmammalian
cells. However, we have identified multiple cell lines from fish (FHM),
mosquitoes (Mos-55), moths (Sf9 and High-5), flies (S2), and frogs
(XPK2) that are not efficiently transduced by MoMLV-based vectors
pseudotyped with many different viral envelope proteins, including
VSV-G, while the same vectors are functional in these cells following
transfection. A comparison of MoMLV-based vector transduction in
mammalian and nonmammalian cells shows that the nonmammalian cells
exhibit blocks at either entry, reverse transcription, or integration.
Additionally, VSV-G-pseudotyped MoMLV-based vector transduction is
attenuated in the zebrafish cell line ZF4 at entry and/or reverse
transcription, whereas other transduction processes are unaffected. We
show that the variation of transduction by MoMLV-based vectors in
mammalian and nonmammalian cells is not due to differences in culture
conditions or cell division rate but is likely the result of divergence
in cellular factors required for retroviral transduction.
 |
INTRODUCTION |
Several cellular factors are
essential for infection by gammaretroviruses, a genus that includes
murine leukemia viruses (MLVs) and other simple retroviruses. Infected
cells express protein receptors which are needed for virus entry, as
well as nucleotides and actin filaments that are required for reverse
transcription (RT) (4, 10). Other proteins, such as
barrier-to-autointegration factor (BAF) and high-mobility group I/Y
(HMGI/Y) proteins, play a role in maintaining proviral DNA prior to
integration (21, 40) and facilitate integration of the
viral preintegration complex (PIC) (17, 23, 24),
respectively. During mitosis the viral PIC gains access to the nucleus,
where integration occurs (22), a process which is thought
to be completed by cellular proteins (43). To better
define the cellular factors which mediate retroviral infection, we
examined transduction in cell types from organisms which are distantly
related to mammals. A genetic approach to studying the processes of
retroviral transduction may lead to the identification of cell types
that can be used to discover additional host factors required for
retrovirus replication.
Retroviral vectors based on gammaretroviruses, particularly those based
on Moloney MLV (MoMLV), are useful for delivering heterologous DNA to
many mammalian and avian cell types. In addition, previous
investigations have indicated that MoMLV-based vectors pseudotyped with
the G glycoprotein from vesicular stomatitis virus (VSV-G) can mediate
gene transfer in cells from fish (5, 25), newts
(6), mosquitoes (26), moths
(13), and frogs (7). Since these initial
studies, subsequent work has been done only with zebrafish, with which
MoMLV-based vectors have been used for insertional mutagenesis in
embryos (14). Aside from the work with fish, most studies
of retroviral transduction in the other nonmammalian cells used
nonquantitative PCR to detect integration events, and therefore gene
transfer efficiency was not measured (6, 7, 13, 26). In
addition, mainly VSV-G-pseudotyped MoMLV-based vectors have been
evaluated for transduction of nonmammalian cells, whereas almost
nothing is known about the expression and functionality of receptors
for naturally occurring retrovirus envelope glycoproteins in these cell types.
As part of a study to investigate factors involved in receptor-mediated
retrovirus entry into cells, we evaluated the susceptibilities of
several nonmammalian cell lines to MoMLV-based vectors pseudotyped with
various viral envelope proteins, including VSV-G. We were surprised to
find that several cell types were not transduced by VSV-G-pseudotyped
MoMLV-based vectors, which prompted us to further investigate the
behavior of these vectors in nonmammalian cells. By comparing the early
steps of retrovirus transduction in canine D17 cells to those in cells
from lower-order organisms, we showed that the processes of virus
entry, RT, and integration differ between the cell types tested. Most
notably, we have observed that mammalian cells are permissive to
VSV-G-pseudotyped MoMLV-based vectors, whereas several nonmammalian
cells have one or more blocks to transduction by these viruses.
Phosphatidyl serine is thought to be the receptor for VSV-G-mediated
virus entry (35, 36). Challenging cells with both VSV-G-pseudotyped retroviral vectors and a recombinant form of VSV that
expresses gfp allowed us to evaluate the relative levels of
receptor expression in the different cell types. Here we show that the
VSV-G envelope poorly facilitates entry of MoMLV-based vectors or VSV
cores into most nonmammalian cells in comparison to mammalian cells.
Furthermore, several nonmammalian cells which were permissive to virus
entry could not support MoMLV-based transduction. Variation in culture
conditions did not explain the discrepancy of MoMLV-based transduction
observed in the different cells, but rather the results of this study
suggest that innate differences between the cell types dictate
transduction efficiency. These findings have important implications for
identifying cellular factors involved in retroviral transduction, as
well as for using retroviral vectors to introduce heterologous DNA
sequences into nonmammalian model organisms.
 |
MATERIALS AND METHODS |
Cell lines and cell culture.
Anopheles gambiae
(Mos-55) (26), Brachydanio rerio (ZF4, ATCC
CRL-2050), and Pimephales promelas (FHM, ATCC CCL-42) cells (kind gifts of Jane Burns, University of California at San Diego, La
Jolla) were maintained at 26°C in Leibovitz's L-15 medium
supplemented with 10% fetal bovine serum (FBS), penicillin, and
streptomycin. Xenopus laevis (XPK2) cells derived from adult
tissue (kind gift of Ron Reeder, Fred Hutchinson Cancer Research
Center, Seattle, Wash.) were maintained at 26°C in 42% L-15
medium-43% water-15% FBS with L-glutamine, penicillin,
and streptomycin. Spodoptera frugiperda cells (Sf9;
Invitrogen) were maintained at 26°C in TNM-FH medium (Sigma)
supplemented with 10% FBS. Trichoplusia ni cells (High-5;
Invitrogen) and Schneider's Drosophila melanogaster cells
(S2; ATCC CRL-1963) (kind gift from Keith Fournier, Fred Hutchinson
Cancer Research Center) were maintained at 26°C in Excell 400 with
L-glutamine (JRH Biosciences). All nonmammalian cells were
grown in air without supplemental CO2.
Canine D17 osteosarcoma cells (ATCC CCL-183), adenovirus 5-transformed
human embryonal kidney 293 cells (ATCC CRL-1573.1), human HT-1080 cells
(ATCC CCL-121), and all retrovirus packaging cells were maintained at
37°C in Dulbecco's minimal essential medium (DMEM) with a high
concentration of glucose (4.5 g/liter) supplemented with 10% FBS,
penicillin, and streptomycin. Cells were grown in a 5%
CO2-air atmosphere.
FHM and D17 cells were adapted to grow at 33°C in a 3%
CO2-air atmosphere. The cells were first grown to 60%
confluence in 25-ml flasks in their normal culture environment (see
above). Once the FHM cells reached 60% confluence, the medium was
changed to 30% conditioned medium from FHM cells and 70% fresh DMEM
supplemented with 10% FBS, penicillin, and streptomycin. The FHM cells
were then passaged two times at 28°C in a 5% CO2-air
atmosphere prior to being transferred to 33°C in a 3%
CO2-air atmosphere. D17 cells which reached 60%
confluence in a 25-ml flask were transferred to an incubator to grow at
33°C in a 3% CO2-air atmosphere. Both cell types were
maintained in DMEM in the new culture environment for several weeks
before they were used for infection assays.
Retroviral vectors.
The retroviral vector LNCZ contains a
neomycin phosphotransferase (neo) gene under the control of
the MoMLV long terminal repeat (LTR) and lacZ under the
control of a cytomegalovirus (CMV) immediate-early promoter. The
retroviral vector LNCG is identical to LNCZ but contains
egfp, which encodes the enhanced green fluorescent protein
(GFP) (Clontech), under the control of the CMV promoter. The plasmid
constructs pLNCZ and pLNCG were made by inserting either
lacZ or egfp into the cloning site of pLNCX
(30).
Transfection assay for gene transfer and expression from pLNCZ or
pLNCG.
One day prior to transfection, the cells were plated in
six-well dishes at 106 (Mos-55), 2 × 105
(S2, High-5, and Sf9), or 105 (ZF4, FHM, and XPK2) cells
per well. Mos-55, S2, ZF4, and FHM cells were transfected with 10 µg
of either pLNCZ or pLNCG by using calcium phosphate coprecipitation
(9). XPK2 cells were transfected with 10 µg of either
plasmid using Lipofectin by following the manufacturer's protocol
(Life Technologies). High-5 and Sf9 cells were transfected with 4 µg
of pLNCZ by using Insectin Plus according to the manufacturer's
protocol (Invitrogen). Expression of
-galactosidase was determined 3 days after transfection by fixing cells with 0.5% glutaraldehyde,
washing cells three times with phosphate-buffered saline (PBS), and
staining for
-galactosidase activity with X-Gal staining solution
[8 mM K3Fe(CN)6, 8 mM
K4Fe(CN)6 · 3H2O, 2 mM
MgCl2, 0.4 mg of X-Gal
(5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside) per
ml].
Virus production.
Different packaging lines that all
contained the MoMLV gag and pol genes were used
to produce the LNCZ vector with envelopes from amphotropic MLV or
gibbon ape leukemia virus (GALV) or to produce the LNCG vector with
envelopes from Mus dunni endogenous virus (MDEV), 10A1
virus, or RD114 virus. The LNCZ(amphotropic) and LNCZ(GALV) viruses
were produced by transducing the PA317 (27) and PG13
(29) packaging lines, respectively, with LNCZ(ecotropic)- virus-containing medium, which was collected 1 day after the
transfection of PE501 (30) packaging cells with pLNCZ. The
LNCG(MDEV) and LNCG(10A1) viruses were produced by transducing the
PD223 (42) and PT67 (28) packaging lines,
respectively, with LNCG(ecotropic)-virus-containing medium, which was
collected 1 day after the transfection of PE501 packaging cells with
pLNCG. The LNCG(RD114) viruses were produced by transducing the FLYRD
(11) packaging lines with
LNCG(amphotropic)-virus-containing medium which was collected 1 day
after the transfection of PA317 packaging cells with pLNCG. All
transductions were done in the presence of 4 µg of Polybrene per ml.
After 24 h, packaging lines containing LNCZ or LNCG were selected
in 700 µg of G418 (active concentration) per ml for 7 to 10 days.
Virus-containing media were collected from confluent dishes of
vector-producing packaging cells and filtered through a
0.45-µm-pore-size filter. All virus stocks were stored at
70°C.
LNCZ was pseudotyped with the VSV-G glycoprotein by calcium phosphate
cotransfection of 293 cells at 50% confluence in a 15-cm dish with 5 µg of pVSV-G, 10 µg of pJK3, 2 µg of pCMVtat, and 15 µg of
pLNCZ per dish (2). pVSV-G encodes the G protein, and pJK3
contains MoMLV gag and pol under the control of
the human immunodeficiency virus type 1 (HIV-1) LTR promoter
(2). pCMVtat encodes the HIV-1 Tat protein, which is
necessary for transactivation of the HIV-1 LTR promoter of pJK3
(2). Fifteen hours posttransfection, fresh medium was
added to the cells, and virus-containing medium was collected every
12 h and filtered. Virus stocks were stored at
70°C. Virus
titers were determined by exposing D17 cells to different amounts of
virus, staining the cells for
-galactosidase, as described above,
and scoring
-galactosidase-positive foci 2 days after virus exposure.
Infection of cells with different pseudotypes of LNCZ or
LNCG.
Virus titers were determined by seeding cells in six-well
plates at the following densities: 105 cells/well for D17
and HT-1080 cells; 5 × 105 cells/well for ZF4, FHM,
XPK2, High-5, and Sf9 cells; and 106 cells/well for Mos-55
cells. After 24 h, the medium was changed to fresh medium
containing 4 µg of Polybrene per ml and then the cells were
inoculated with different dilutions of virus. Infected cells were
incubated in their normal culture environment for 3 days. Afterwards,
cells receiving MoMLV-based LNCZ vectors were washed once in PBS, fixed
for 5 min in 0.5% glutaraldehyde, rinsed three times with PBS, and
stained overnight at 37°C for
-galactosidase activity. Cells
inoculated with virus having the LNCG vector were observed under a
fluorescence microscope, and GFP+ foci were scored.
Production of LNCZ(VSV-G) for quantitative PCR.
LNCZ(VSV-G)
was produced from a monoclonal population of 293 cells containing one
copy of pLNCZ known to have the XbaI site only in the 3'
LTR. To generate these cells, 293 cells were transfected with 5 µg of
pLNCZ using the calcium phosphate method and were subsequently selected
in 700 µg of G418 (active concentration) per ml for 10 days. Clonal
populations were first screened for
-galactosidase activity and then
by Southern analysis for the presence of the XbaI site in
the 3' LTR of the vector. Clone 12 (293/LNCZ-c12) had the desired
properties and was transfected with pVSV-G, pJK3, and pCMVtat for
production of LNCZ(VSV-G) as described above. Virus titers were
determined by exposing D17 cells to different amounts of virus and
scoring positive foci of cells expressing the marker proteins.
Quantification of RT products.
One day before infection,
cells were plated in six-well dishes at 105 (D17, ZF4,
XPK2, and FHM) or 106 (Mos-55) cells per well. Cells were
exposed to LNCZ(VSV-G) at a multiplicity of infection (MOI) of 0.03. All infections were done in the presence of 4 µg of Polybrene per ml,
whereas mock-infected cells received medium containing Polybrene only.
Eighteen hours postinfection, the cells were trypsinized, collected,
and rinsed in PBS. Fractions containing Hirt DNA and genomic DNA were
obtained using the Hirt extraction method (18). Hirt DNA
was resuspended in 25 µl of water, and 2 µl was used for PCR
amplification in a total reaction volume of 100 µl. Hirt DNA was
amplified for 35 rounds using primers U3a (5'
AGTTCAGATCAAGGTCAGG3') and PSIa (5'TTAGGGTGTACAAAGGGC3').
For competitive PCR, Hirt DNA was amplified in the presence of 0, 0.1, 1, 10, 100, or 1,000 copies of a competitor (pLNCZ). Ten
microliters of product from each PCR was digested with 5 U of
XbaI at 37°C for 2 h. Samples were analyzed by gel electrophoresis on 1% agarose and were transferred to nylon membranes (Hybond-N; Amersham) for Southern analysis. Membranes were probed with
a 677-bp Asp718-to-BstEII fragment of the LNCZ
vector, which was purified with the QiaexII DNA purification kit
(Qiagen). The 677-bp fragment hybridizes to R and U5 of the LTR, as
well as to a portion of the packaging signal within the LNCZ vector.
Doubling times of cells.
All cell types were plated and
cultured under the same conditions as were used for infection. Cells
were seeded in six-well plates at the following densities:
105 cells/well for D17 and HT1080 cells; 5 × 105 cells/well for ZF4, FHM, XPK2, High-5, and Sf9 cells;
and 106 cells/well for Mos-55 cells. Cells were trypsinized
and counted every 24 h for 4 days. Doubling times were determined
between days 2 and 4, the times during which the cells were exposed to virus in other experiments.
Exogenous RT assays.
Each reaction mixture contained 250 µl of RT cocktail {50 mM Tris (pH 7.8), 60 mM NaCl, 2 mM
dithiothreitol, 0.6 mM MnCl2, 0.05% NP-40, 10 µM dTTP,
12.5 µg of poly(A)(dTTP)10 (Sigma), and 2 µl of
800-µCi/mol [32P]dTTP in a final volume of 1,000 µl}. Two hundred fifty microliters of cocktail was combined with 5 µl of LNCG(RD114), which had a titer of 105 focus-forming
units (FFU)/ml in HT-1080 cells, or filtered conditioned medium from
HT-1080 cells, the parental cell line used to make the LNCG(RD114)
packaging cells. Reaction mixtures were incubated in water baths at 37 or 26°C. Three 10-µl samples from each reaction mixture were taken
every 15 min, blotted onto DE-81 paper, and dried for 5 min at room
temperature. Blots were washed four times at room temperature in saline
sodium citrate for 5 min followed by two 5-min washes in 95% ethanol.
Blots were dried and suspended in scintillation fluid for determining
[32P]dTTP incorporation.
Endogenous RT assays.
Ten microliters of LNCG(RD114) or
conditioned medium from the FLYRD packaging line was added to a 60-µl
reaction mixture containing 50 mM Tris(pH 8.3), 15 mM dithiothreitol, 7 mM magnesium acetate, 0.01% NP-40, and 8 mM (each) dTTP, dATP, dGTP,
and dCTP. Samples were incubated for 20 h, and aliquots were
stored at
20°C until used for PCR amplification. Samples were
amplified with primers PSIa and U3a (described above) in the presence
of a pLNCZ competitor ranging from 102 to 107
molecules and pUC18 for a final DNA concentration of 1 pg/µl. Fifteen
microliters of each sample was analyzed by 1% agarose gel
electrophoresis and ethidium bromide staining.
 |
RESULTS |
The CMV immediate-early promoter and either
-galactosidase or
GFP reporters work best to measure transduction in nonmammalian
cells.
We assayed
-galactosidase, human placental alkaline
phosphatase (AP), and GFP expression from several promoters to
determine the best promoter and reporter proteins for use in the
nonmammalian cells used in this study. Sf9, S2, and High-5 cells were
transfected with expression constructs containing either LacZ or AP
cDNA under the control of one of the following promoters: the CMV
promoter, the Drosophila armadillo promoter (Arm), or the
MoMLV LTR promoter. FHM, ZF4, Mos-55, and XPK2 cells were transfected
with the same constructs except those containing the Arm promoter.
Reporter expression was evaluated 3 days posttransfection by staining
cells for
-galactosidase or AP activity. We found that the MoMLV LTR promoter functioned only in the FHM cells, whereas the CMV promoter drove the expression of
-galactosidase in all cell types tested. The
Arm promoter also worked in a few cell lines (Sf9, S2, and High-5), but
the marker gene activity in most cells was higher with the CMV promoter
(data not shown).
Some cell lines (XPK2, ZF4, High-5, Sf9, and S2) had relatively high
levels of endogenous, heat-resistant AP activity that masked detection
of activity from the transferred AP gene. Since all cells transfected
with the
-galactosidase marker were easy to score, we constructed a
new retroviral vector (LNCZ) that contained lacZ under the
control of the CMV promoter (Fig. 1).
Expression of the reporter from both pLNCZ and a similar plasmid
encoding GFP (pLNCG) was subsequently tested in most of the cell types used in this study (Fig. 1; Table 1).
Bright foci were seen in all of the cell lines transfected with either
plasmid, although some cell lines had fewer foci than others,
suggesting poor transfection efficiency (Table 1). These results show
that
-galactosidase and/or GFP reporters from these vectors are
expressed in all cell types tested, making them good markers for the
assay of retroviral transduction.

View larger version (5K):
[in this window]
[in a new window]
|
FIG. 1.
Diagram of MoMLV based retroviral vectors. Both LNCG and
LNCZ contain retroviral LTRs, which drive the expression of the
neomycin phosphotransferase (neo) gene and contain the
polyadenylation signal (pA). The CMV promoter drives the expression of
lacZ and gfp in LNCZ and LNCG, respectively.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Most nonmammalian cells tested were resistant to
transduction by MoMLV-based vectors but susceptible to transfection
by vector plasmids
|
|
Of the nonmammalian cell lines tested, only one is transduced by
MoMLV-based vectors.
To determine whether retroviral vectors could
transduce nonmammalian cells, we challenged the cells with LNCZ or LNCG
vectors pseudotyped with various viral envelopes that have relatively broad host ranges in mammalian cell lines. The MoMLV-based vector LNCZ
was pseudotyped with either the amphotropic, GALV, or VSV-G envelope,
and LNCG was pseudotyped with either the MLV 10A1, MDEV, or RD114
envelope. Nonmammalian cells were infected at MOIs ranging from 0.1 to
100, and titers were compared to those found with mammalian D17 and
HT-1080 cells (Table 1).
All of the cells tested were resistant to transduction by the
MoMLV-based vectors except for the ZF4 cells, which were permissive to
transduction by vectors pseudotyped with either the GALV, RD114, or
VSV-G envelope. However, these viruses consistently had lower titers in
ZF4 cells than in D17 or HT-1080 cells (Table 1).
Unlike ZF4 cells, the other nonmammalian cells were not transduced by
LNCZ or LNCG vectors pseudotyped with any envelope. However, exposure
of the Xenopus cell type XPK2 to vectors having either the
GALV or amphotropic pseudotypes produced remarkable syncytium formation
in the cell monolayer (Fig. 2). Several
other viral envelopes did not have this effect on XPK2 cells,
suggesting that these cells specifically express high levels of the
Pit1 (32) and Pit2 (31) receptors for GALV
and the amphotropic virus, respectively. Despite the presence of
virus-induced syncytia in XPK2 cells, the cells were not transduced by
any vector pseudotyped with these two envelopes. The general lack of
transduction by vectors having pseudotypes with a broad host range,
including the pantropic VSV-G pseudotype, indicates that these cells
may have blocks to MoMLV-based transduction that occur subsequent to
virus entry.

View larger version (137K):
[in this window]
[in a new window]
|
FIG. 2.
Syncytium formation in frog cells exposed to MoMLV-based
vectors pseudotyped with either GALV or amphotropic envelope. XPK2
cells were treated with 4 µg of Polybrene per ml with no additions
(A) or with 104 FFU of LNCZ(PG13) (B) or LNCZ(PA317) (C).
Panel D shows a syncytium with ~75 nuclei. Photos were taken 24 h after virus exposure.
|
|
With the exception of XPK2 cells, all of the nonmammalian cell
types tested are susceptible to infection by recombinant VSV.
The
lack of transduction by VSV-G-pseudotyped vectors of so many
nonmammalian cell types prompted us to investigate whether the VSV
receptor was expressed in these cells. To address this we utilized a
recombinant form of VSV which has the gfp gene inserted between the G (glycoprotein) and L (large subunit of RNA polymerase) genes of wild-type VSV. The normal gene order of VSV is
3'-N-P-M-G-L-5', with expression controlled at the level of
transcription by the viral RNA-dependent RNA polymerase (1,
21). VSV carries its RNA polymerase into the cytoplasm of cells,
where it subsequently transcribes the single-stranded RNA genome in the
absence of de novo protein synthesis. Because VSV replicates in most
cell types, the expression of GFP by recombinant VSV (VSV-GFP) is a
good marker for virus entry.
VSV-GFP could transduce all cells tested except XPK2 (Table 1).
Equivalent titers of VSV-GFP were observed in Mos-55 and D17 cells, but
the titers in other cells were reduced by as much as 7 orders of
magnitude (Table 1). These data show that all but one of the
nonmammalian cell lines express functional receptors for VSV-G and
support the hypothesis that these cells have postentry blocks to
transduction by VSV-G-pseudotyped MoMLV-based vectors.
Nonmammalian cells have less RT product than D17 cells after
infection with LNCZ(VSV-G).
Although we observed entry of VSV-GFP
in most of the nonmammalian cell types, it was still uncertain whether
retroviral vectors pseudotyped with VSV-G could enter the cells.
Detection of late products of RT within infected cells can be used as a
marker for retrovirus entry (38). Strong-stop DNA is the
first minus-strand DNA made during RT and is commonly found within
incoming virions. However, late RT products such as full-length minus-
and plus-strand DNAs are made only in newly infected cells. Therefore,
we designed a PCR protocol that specifically identifies full-length RT
products in cells infected with LNCZ(VSV-G) as follows (Fig.
3).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
Schematic representation of the assay used to detect and
quantify RT products from infected cells. The packaging line contains
plasmid DNA from the transfection of 293 cells with pLNCZ. After
transcription of the pLNCZ vector, the viral RNA contains an
XbaI restriction site in the U3 region of the 3'LTR. RT of
the LNCZ vector copies the XbaI restriction site to the
5'LTR in the double-stranded DNA. Small arrows depict the location of
primers used to amplify RT products and competitor plasmid DNA. The two
products could be distinguished by restriction analysis with
XbaI followed by gel electrophoresis.
|
|
During RT the U3 region of the 3' LTR is copied to the 5' LTR of the
provirus DNA (15). The LNCZ vector contains an
XbaI restriction site in the 3' MoMLV LTR but not in the 5'
Moloney murine sarcoma virus LTR (Fig. 3B). Strand transfer steps which occur during RT of LNCZ produce a full-length RT product with an
XbaI restriction site in the U3 region of the 5' LTR (Fig. 3C). This site is distinguished from plasmid DNA which lacks the XbaI site in the same region of the provirus (Fig. 3A).
Therefore, PCR amplification of this region followed by digestion with
XbaI allowed us to detect and quantify the amount of RT
product in cells infected with LNCZ(VSV-G) (Fig.
4A).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Quantification of RT products in cells infected with
LNCZ(VSVG). (A) Analysis of D17 cells subjected to quantitative
competitive PCR followed by Southern analysis. Lanes: 1 and 2, undigested PCR-amplified Hirt DNA from uninfected cells and cells
infected with LNCZ(VSVG), respectively; 3 to 8, samples of Hirt DNA
from infected cells which has been PCR amplified in the presence of 0, 0.1, 1, 10, 100, or 1,000 copies respectively, of competitor pLNCZ
plasmid followed by digestion with XbaI. (B) Relative
percentages of RT products found in nonmammalian cells normalized to
D17 cells. Percentages are based on an average of two experiments.
Variation between experiments was <5-fold.
|
|
Hirt DNA was obtained from cells infected with LNCZ(VSV-G) produced
from 293 cells containing a single nonrearranged LNCZ provirus. Hirt
DNA was PCR amplified, digested with XbaI, and subjected to
Southern analysis. RT products were detected in all cells exposed to
LNCZ(VSV-G) but in amounts which were 100- to 1,000-fold lower than
those found in D17 cells (Fig. 4B). Using the same assay, viral stocks
were analyzed for full-length RT products but none were detected (data
not shown), indicating that all RT products were made after virion
entry into cells. These data confirm that all nonmammalian cells tested
can support both entry and RT of MoMLV-based vectors pseudotyped with
VSV-G and that blocks to transduction in these cells occur after these
processes. Furthermore, VSV-GFP infected Mos-55 and D17 cells
equivalently, but the amount of RT product in Mos-55 cells infected
with LNCZ(VSV-G) was 100-fold lower than the amount of RT product found
in D17 cells infected with an equivalent MOI (Table
2; Fig. 4B). The VSV-G envelope promotes
efficient virus entry in both D17 and Mos-55 cells; therefore, the
difference between transduction with LNCZ(VSV-G) and infection with
VSV-GFP in these two cell types is likely due to an inhibition which
occurs before or during RT and prior to integration but is not a block
at virus entry.
The temperature at which nonmammalian cells are grown does not
influence the RDDP activity of MoMLV reverse transcriptase in
vitro.
To investigate the postentry attenuation to RT in the
nonmammalian cells, we determined whether culture temperatures could account for the low levels of RT products found in these cells. Therefore, we examined the RNA-dependent DNA polymerase (RDDP) activity
of MoMLV reverse transcriptase at two different temperatures at which
nonmammalian and D17 cells are grown, 26 and 37°C, respectively. Exogenous RDDP assays were performed using medium containing
LNCG(RD114) as a source of MoMLV reverse transcriptase. Background
activity was assessed with conditioned medium from HT-1080 cells, the
parental cell type used to produce the FLYRD retrovirus packaging
cells. We found that the RDDP activity of MoMLV reverse transcriptase was reduced by <2-fold at 26°C compared to the activity at 37°C (Fig. 5A). However, the small difference
in RDDP activity at the two temperatures does not explain why
nonmammalian and D17 cells infected with LNCZ(VSV-G) have 100- to
1,000-fold differences in the total amount of RT product.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 5.
Temperature effect on MoMLV reverse transcriptase.
(A) Exogenous RT assay to assess RDDP activity. Incorporation of
[32P]dTTP into a poly(A)(dTTP)12
template-primer mixture by MoMLV reverse transcriptase at 26°C ( )
or 37°C ( ) was measured. Incorporation in HT-1080 conditioned
medium at 37°C ( ) served as a control. (B) Endogenous RT assay to
assess complete activity of MoMLV reverse transcriptase at 26 and
37°C. DNAs from the endogenous RT assays done at the two different
temperatures were used as templates for PCR amplification of the
LTR- sequence without nonspecific (pUC18) DNA (lanes 1 and 18), with
nonspecific DNA only (lanes 2 and 19), or in the presence of
102 to 107 copies of pLNCZ competitor and
nonspecific DNA (lanes 3 to 8 and 20 to 25). Amplification of the
competitor only (lanes 10 to 15 and 27 to 32), nonspecific DNA only
(lanes 16 and 33), no template (lanes 9 and 26), and conditioned medium
from mock producer cells (lanes 17 and 34) served as negative controls.
The assay was repeated under the same conditions to confirm the results
(data not shown).
|
|
DDDP activity and other processes of MoMLV RT are comparable at 26 and 37°C.
To investigate if MoMLV reverse transcriptase could
efficiently complete strand transfer, strand displacement, and
DNA-dependent DNA polymerase (DDDP) activities at lower
temperatures, we performed endogenous RT assays at 26 and 37°C.
Endogenous RT assays differ from exogenous RT assays in that the former
are performed within permeabilized viruses and utilize the viral RNA as
a template for RT (33, 39). Endogenous RT assays were done
with LNCG(RD114) or conditioned medium from the FLYRD cell-based
packaging line not containing a retroviral vector. A portion of each
sample was subjected to PCR amplification in the presence of
102 to 107 molecules of plasmid DNA (pLNCZ) and
nonspecific DNA (pUC18) to obtain an equal amount of DNA in each
reaction mixture. By comparing amplified samples having no competitor
(Fig. 5B, lanes 2 and 19) to those with competitor (Fig. 5B, lanes 3 to
8 and 20 to 25), we were able to determine the relative amounts of
total RT products found in each endogenous reaction performed at either 26 or 37°C. We found that at both temperatures there were
approximately 105 molecules of full-length RT product, thus
indicating that RT does not significantly differ between 26 and 37°C.
Temperatures at which FHM cells grow do not influence MoMLV-based
transduction in vivo.
To evaluate whether another step in
transduction was affected by temperature, we adapted D17 cells and FHM
cells to grow under identical culture conditions. Both cell types were
adapted to grow at 33°C in a 3% CO2-air atmosphere and
were later challenged with LNCZ(VSV-G). Titers were at least 5 orders
of magnitude higher in D17 cells than in FHM cells. The lack of
transduction by LNCZ(VSV-G) in FHM cells grown under the same culture
conditions as D17 cells indicates that FHM cells lack cellular
factors required for transduction by LNCZ(VSV-G) or that these
cells contain an inhibitor of MoMLV-based vector transduction. These
findings are supported by data which show that these vectors enter and
undergo RT but fail to transduce the cells.
The lack of transduction by MoMLV-based vectors in nonmammalian
cells is not due to a low rate of cell division at the time of
infection.
Because the MoMLV PIC enters the nucleus only during
mitosis, we wanted to determine whether the division rates of the
nonmammalian cells might be lower than those of mammalian cells,
thereby reducing the frequency of mitosis and thus the rate of
transduction by MoMLV-based vectors. Therefore, we evaluated the
doubling time of each cell line at the time of infection (Table 2). All
cell types were plated and cultured under the same conditions as used for infection. We determined the doubling time for each cell type by
counting cells every 24 h after plating. The FHM, High-5, and Mos-55 cells had shorter doubling times than the permissive ZF4 cells,
yet none were permissive to transduction by MoMLV-based vectors. XPK2
cells divided at a rate which was slightly lower than that of ZF4
cells, whereas Sf9 cells divided at a markedly lower rate. Therefore,
it is possible that the low division rate of Sf9 cells affects the
transduction of these cells by MoMLV-based vectors. These data show
that RT products found in most of the nonmammalian cell types 24 h
posttransduction (Table 2; Fig. 4B) should have access to the nucleus
and indicate that these cells likely have blocks to transduction by
MoMLV-based vectors that are independent of nuclear entry.
 |
DISCUSSION |
Here we report that several nonmammalian cell types exhibit blocks
to MoMLV-based vector transduction. Many of the nonmammalian cell types
tested were not transduced by MoMLV-based vectors pseudotyped with
pantropic envelopes. The striking contrast between the transduction efficiency observed in mammalian and nonmammalian cells led us to
investigate at what step MoMLV-based transduction was inhibited or
blocked. Our data, summarized in Fig. 6,
show that some nonmammalian cells have various postentry blocks or
attenuations to MoMLV-based transduction during or prior to RT and at
the step of integration. The differences in growth temperatures do not
account for the relatively low levels of RT products found in the
nonmammalian cells tested or for the failure of vector integration and
lack of reporter expression in FHM cells. Interestingly, many
nonmammalian cells that contain RT products after exposure to viruses
containing MoMLV-based vectors are not permissive to transduction by
these vectors even though they divide at rates which are comparable to
those of permissive cells. In general, we found that in several nonmammalian cell types MoMLV-based transduction is blocked or attenuated at multiple early steps required for the expression of
heterologous DNA from an MoMLV-based vector.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 6.
Schematic representation of blocks to MoMLV-based
transduction in various cell types. Arrows show the procession of
transduction through the three main steps. Solid lines represent
uninterrupted events, and dashed lines represent disrupted events. Bars
indicate a complete block to transduction after RT. D17 cells are the
cells to which all of the other cell types were compared. ZF4 cells
contain 100-fold fewer RT products than do D17 cells, and the titers of
LNCZ(VSV-G) are also 100-fold lower than those of D17 cells. Mos-55
cells have 100-fold fewer RT products than do D17 cells, but the entry
of LNCZ(VSV-G) is comparable in the two cell types as assessed by
VSV-GFP titers. Furthermore, the RT products in Mos-55 cells do not
lead to transduction events. XPK2, FHM, and High-5 cells contain 2 to 3 orders of magnitude fewer RT products than do D17 cells, and the RT
products do not lead to transduction events.
|
|
It was unexpected that most of the nonmammalian cells could not be
transduced by MoMLV-based vectors pseudotyped with envelopes from viruses which have broad host ranges. Earlier work has shown that
MoMLV-based vectors pseudotyped with the MDEV envelope can efficiently
transduce species such as the rat, hamster, quail, cat, dog, human, and
mouse (3). Previously, there were no reports of a cell
line which MDEV vectors could not transduce. Likewise, VSV-G-pseudotyped viruses have been referred to as pantropic because the receptor is thought to be a phospholipid, a component of most cellular membranes. Therefore, we were surprised to find that several
nonmammalian cells were not transduced by MoMLV-based vectors
pseudotyped with MDEV or VSV-G viral envelopes, even though these
vectors are expressed when transfected into the same nonmammalian cells. Similarly, we expected to observe transduction in XPK2 cells
infected with either LNCZ(GALV) or LNCZ(amphotropic) because these
viruses caused dramatic syncytium formation shortly after infection,
and yet they were negative for
-galactosidase expression. It remains
unclear if High-5, Sf9, S2, FHM, and Mos-55 cells express the receptors
for MDEV, 10A1 virus, amphotropic virus, and GALV.
The identification of de novo RT products in the nonmammalian cells
infected with LNCZ(VSV-G) confirmed that the pseudotyped viruses
entered the cells. However, the efficiency of virus entry in some of
the cell types is not known because some of the cells were poorly
infected by both LNCZ(VSV-G) and VSV-GFP. For example, the XPK2 cells
did not support the replication of VSV-GFP, but entry was established
by the detection of RT products after infection with LNCZ(VSV-G).
Therefore, it is possible that the relatively low levels of RT products
in some of the cell types can be ascribed to poor virus entry. On the
other hand, infection with VSV-GFP showed that a few of the
nonmammalian cell types should be very permissive to vectors
pseudotyped with VSV-G envelopes. In agreement with previous studies
that have demonstrated productive infection of wild-type VSV in
mosquitoes (37), we found that Mos-55 cells were extremely
permissive to VSV-GFP. Remarkably, the same cells were not transduced
by MoMLV-based vectors pseudotyped with VSV-G, thus demonstrating that
transduction is blocked for reasons other than inefficient virus entry.
In contrast to our results, one study has demonstrated integration
of MoMLV-based vectors pseudotyped with VSV-G in Mos-55 cells
(26). However, in that study nested PCR identified only
two integrated events from a pool of cells which were infected at an
MOI of 0.3. These findings suggest that integration of MoMLV-based
vectors in Mos-55 cells is extremely rare at best. In our study, we
used colorimetric titering assays to measure transduction in Mos-55
cells and did not find any such events even when infections were done
at an MOI of >5 (data not shown). Regardless, we were able to detect
entry of either LNCZ(VSV-G) or VSV-GFP in the nonmammalian cell
types, and we hypothesize that the lack of transduction by
LNCZ(VSV-G) or LNCG(VSV-G) must be attributable to postentry blocks.
The dramatic variation between MoMLV-based transduction in mammalian
and nonmammalian cells is not due to differences in culture conditions.
Previous reports indicated that the optimal activity of MoMLV reverse
transcriptase occurs at temperatures between 39 and 41°C
(34). We found the RDDP activity of MoMLV reverse transcriptase to be only slightly greater at 37°C than at 26°C. Consistent with another report by Whiting and Champoux
(41), we found the processes of strand transfer and strand
displacement and the DDDP activity of reverse transcriptase to be
comparable at 37 and 26°C. Therefore, the relatively low levels of RT
products found in the nonmammalian cells were not due to differences in culture temperatures. Along these lines, MoMLV-based transduction in
FHM cells could not be rescued by adapting the cells to grow at
temperatures which are sufficient for transduction in mammalian cells.
Therefore, other reasons, such as a deficiency in specific cellular
factors or the presence of an inhibitory factor, account for the lack
of transduction in the nonmammalian cells.
Cellular factors which are required for early events in MoMLV
replication may be absent in the nonmammalian cells tested in this
study. MoMLV enzymatic proteins are sufficient to produce full-length
double-stranded DNA products in vitro, but it is unclear if other
factors are required in vivo (12, 15). Previous studies of
HIV-1 show a role for casein kinase II (16), the HIV-1
coreceptor (8), actin filaments, and possibly
actin-binding proteins in the early steps of RT (4). Since
little is known about the intracellular composition of the MoMLV RT
machinery, it is unclear if host factors other than nucleotides are
needed to produce a full-length cDNA from incoming viral RNA. The MoMLV
PIC includes BAF, a cellular factor which binds retroviral cDNA at a
relatively late time during RT (17). Although a function
for BAF in RT has not been identified, it is known that BAF's
association with the MoMLV PIC prevents autointegration
(21) and may play an indirect role in creating a proper
intasome structure necessary for integration of viral DNA into the host
cell genome (40). Interestingly, a mutant of BAF that
cannot bind DNA restores the integration activity of salt-stripped
HIV-1 PICs in vitro, suggesting that BAF interacts with other
components of the viral PIC in addition to DNA (17).
BAF's interaction with HIV-1 PICs may be through association with
other cellular factors which might also be present in MoMLV PICs.
Another group has used reconstituted salt-stripped MoMLV PICs for in
vitro intermolecular integration assays and established the need for
the host factor HMGI/Y in retroviral integration (23).
However, in that study extracts from NIH 3T3 cells were able to
complement salt-stripped PICs better than purified HMGI/Y, suggesting
that additional cellular factors may play a role in MoMLV integration.
With so many cellular factors involved in MoMLV-based transduction, it
would perhaps be unlikely that nonmammalian cells contain all of the
mammalian homologs which are required for the process or that they
would contain them in sufficient quantities. For example, poor
MoMLV-based transduction efficiencies in several zebrafish cell types
(data not shown) could be the result of insufficient quantities of
cellular factors. In agreement with our results, other groups found
that titers of VSV-G-pseudotyped MoMLV-based vectors are 100-fold lower
in zebrafish cells than in hamster cells (5) and proposed
that the difference may be due to the dissimilarity of host factors
within the two cell types (20). Likewise, species-specific
postentry blocks have been reported for human and primate
immunodeficiency viruses in various mammalian cell types
(19). Alternatively, we cannot rule out an inhibitory mechanism which would prevent MoMLV-based transduction in many of the
nonmammalian cells which displayed a complete block to transduction. In
either case, the identification of postentry blocks to transduction in
the nonmammalian cells provides a method for identifying cellular
factors involved in the early steps of MoMLV replication. Currently, we
are attempting to rescue MoMLV-based transduction in FHM cells by
providing these cells with chromosomes from zebrafish cells which are
transduced by these vectors. The many cell lines displaying different
postentry blocks to transduction by MoMLV-based vectors create new
opportunities for studying retroviral infection.
 |
ACKNOWLEDGMENTS |
We thank Marie Vodicka for her suggestions and comments on the
manuscript; Jane Burns for the Mos-55, FHM, and ZF4 cells; Ron Reeder
for the XPK2 cells; Keith Fournier for the S2 cells; Jack Rose for
recombinant VSV; Michael Emerman for the Sf9 and High-5 cells; and
Becca Gottschalk and Neal Van Hoeven for LNCG.
This work was supported by NIH training grant GM07270, distributed
through the Molecular and Cellular Biology Program at the University of
Washington, and NIH grant HL54881.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Fred Hutchinson
Cancer Research Center, 1100 Fairview Ave. N., Room C2-105, Seattle, WA
98109-1024. Phone: (206) 667-2890. Fax: (206) 667-6523. E-mail: dmiller{at}fhcrc.org.
 |
REFERENCES |
| 1.
|
Ball, L. A.,
C. R. Pringle,
B. Flanagan,
V. P. Perepelitsa, and G. W. Wertz.
1999.
Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus.
J. Virol.
73:4705-4712[Abstract/Free Full Text].
|
| 2.
|
Bartz, S. R., and M. A. Vodicka.
1997.
Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
Methods
12:337-342[CrossRef][Medline].
|
| 3.
|
Bonham, L.,
G. Wolgamot, and A. D. Miller.
1997.
Molecular cloning of Mus dunni endogenous virus: an unusual retrovirus in a new murine viral interference group with a wide host range.
J. Virol.
71:4663-4670[Abstract].
|
| 4.
|
Bukrinskaya, A.,
B. Brichacek,
A. Mann, and M. Stevenson.
1998.
Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton.
J. Exp. Med.
188:2113-2125[Abstract/Free Full Text].
|
| 5.
|
Burns, J. C.,
T. Friedmann,
W. Driever,
M. Burrascano, and J. K. Yee.
1993.
Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells.
Proc. Natl. Acad. Sci. USA
90:8033-8037[Abstract/Free Full Text].
|
| 6.
|
Burns, J. C.,
T. Matsubara,
G. Lozinski,
J. K. Yee,
T. Friedmann,
C. H. Washabaugh, and P. A. Tsonis.
1994.
Pantropic retroviral vector-mediated gene transfer, integration, and expression in cultured newt limb cells.
Dev. Biol.
165:285-289[CrossRef][Medline].
|
| 7.
|
Burns, J. C.,
L. McNeill,
C. Shimizu,
T. Matsubara,
J. K. Yee,
T. Friedmann,
B. Kurdi-Haidar,
E. Maliwat, and C. E. Holt.
1996.
Retroviral gene transfer in Xenopus cell lines and embryos.
In Vitro Cell. Dev. Biol. Anim.
32:78-84[Medline].
|
| 8.
|
Chackerian, B.,
E. M. Long,
P. A. Luciw, and J. Overbaugh.
1997.
Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection.
J. Virol.
71:3932-3939[Abstract].
|
| 9.
|
Chen, C., and H. Okayama.
1987.
High-efficiency transformation of mammalian cells by plasmid DNA.
Mol. Cell. Biol.
7:2745-2752[Abstract/Free Full Text].
|
| 10.
|
Coffin, J. M.,
S. H. Hughes, and H. E. Varmus.
1997.
Retroviruses.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 11.
|
Cosset, F.-L.,
Y. Takeuchi,
J.-L. Battini,
R. A. Weiss, and M. K. L. Collins.
1995.
High-titer packaging cells producing recombinant retroviruses resistant to human serum.
J. Virol.
69:7430-7436[Abstract].
|
| 12.
|
Fassati, A., and S. P. Goff.
1999.
Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus.
J. Virol.
73:8919-8925[Abstract/Free Full Text].
|
| 13.
|
Franco, M.,
M. E. Rogers,
C. Shimizu,
H. Shike,
R. G. Vogt, and J. C. Burns.
1998.
Infection of lepidoptera with a pseudotyped retroviral vector.
Insect Biochem. Mol. Biol.
28:819-825[CrossRef][Medline].
|
| 14.
|
Gaiano, N.,
A. Amsterdam,
K. Kawakami,
M. Allende,
T. Becker, and N. Hopkins.
1996.
Insertional mutagenesis and rapid cloning of essential genes in zebrafish.
Nature
383:829-832[CrossRef][Medline].
|
| 15.
|
Gilboa, E.,
S. W. Mitra,
S. Goff, and D. Baltimore.
1979.
A detailed model of reverse transcription and tests of crucial aspects.
Cell
18:93-100[CrossRef][Medline].
|
| 16.
|
Harada, S.,
T. Maekawa,
E. Haneda,
Y. Morikawa,
N. Nagata, and K. Ohtsuki.
1998.
Biochemical characterization of recombinant HIV-1 reverse transcriptase (rRT) as a glycyrrhizin-binding protein and the CK-II-mediated stimulation of rRT activity potently inhibited by glycyrrhetinic acid derivative.
Biol. Pharm. Bull.
21:1282-1285[Medline].
|
| 17.
|
Harris, D., and A. Engelman.
2000.
Both the structure and DNA binding function of the barrier-to-autointegration factor contribute to reconstitution of HIV type 1 integration in vitro.
J. Biol. Chem.
275:39671-39677[Abstract/Free Full Text].
|
| 18.
|
Hirt, B.
1967.
Selective extraction of polyoma DNA from infected mouse cell cultures.
J. Mol. Biol.
26:365-369[CrossRef][Medline].
|
| 19.
|
Hofmann, W.,
D. Schubert,
J. LaBonte,
L. Munson,
S. Gibson,
J. Scammell,
P. Ferrigno, and J. Sodroski.
1999.
Species-specific, postentry barriers to primate immunodeficiency virus infection.
J. Virol.
73:10020-10028[Abstract/Free Full Text].
|
| 20.
|
Hopkins, N.
1993.
High titers of retrovirus (vesicular stomatitis virus) pseudotypes, at last.
Proc. Natl. Acad. Sci. USA
90:8759-8760[Free Full Text].
|
| 21.
|
Lee, M. S., and R. Craigie.
1998.
A previously unidentified host protein protects retroviral DNA from autointegration.
Proc. Natl. Acad. Sci. USA
95:1528-1533[Abstract/Free Full Text].
|
| 22.
|
Lewis, P. F., and M. Emerman.
1994.
Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus.
J. Virol.
68:510-516[Abstract/Free Full Text].
|
| 23.
|
Li, L.,
C. M. Farnet,
W. F. Anderson, and F. D. Bushman.
1998.
Modulation of activity of Moloney murine leukemia virus preintegration complexes by host factors in vitro.
J. Virol.
72:2125-2131[Abstract/Free Full Text].
|
| 24.
|
Li, L.,
K. Yoder,
M. S. T. Hansen,
J. Olvera,
M. D. Miller, and F. D. Bushman.
2000.
Retroviral cDNA integration: stimulation by HMG I family proteins.
J. Virol.
74:10965-10974[Abstract/Free Full Text].
|
| 25.
|
Lin, S.,
N. Gaiano,
P. Culp,
J. C. Burns,
T. Friedmann,
J. K. Yee, and N. Hopkins.
1994.
Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish.
Science
265:666-669[Abstract/Free Full Text].
|
| 26.
|
Matsubara, T.,
R. W. Beeman,
H. Shike,
N. J. Besansky,
O. Mukabayire,
S. Higgs,
A. A. James, and J. C. Burns.
1996.
Pantropic retroviral vectors integrate and express in cells of the malaria mosquito, Anopheles gambiae.
Proc. Natl. Acad. Sci. USA
93:6181-6185[Abstract/Free Full Text].
|
| 27.
|
Miller, A. D., and C. Buttimore.
1986.
Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.
Mol. Cell. Biol.
6:2895-2902[Abstract/Free Full Text].
|
| 28.
|
Miller, A. D., and F. Chen.
1996.
Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry.
J. Virol.
70:5564-5571[Abstract/Free Full Text].
|
| 29.
|
Miller, A. D.,
J. V. Garcia,
N. von Suhr,
C. M. Lynch,
C. Wilson, and M. V. Eiden.
1991.
Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus.
J. Virol.
65:2220-2224[Abstract/Free Full Text].
|
| 30.
|
Miller, A. D., and G. J. Rosman.
1989.
Improved retroviral vectors for gene transfer and expression.
BioTechniques
7:980-982[Medline], 984-986, 989-990.
|
| 31.
|
Miller, D. G.,
R. H. Edwards, and A. D. Miller.
1994.
Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus.
Proc. Natl. Acad. Sci. USA
91:78-82[Abstract/Free Full Text].
|
| 32.
|
O'Hara, B.,
S. V. Johann,
H. P. Klinger,
D. G. Blair,
H. Rubinson,
K. J. Dunn,
P. Sass,
S. M. Vitek, and T. Robins.
1990.
Characterization of a human gene conferring sensitivity to infection by gibbon ape leukemia virus.
Cell Growth Differ.
1:119-127[Abstract].
|
| 33.
|
Rothenberg, E., and D. Baltimore.
1977.
Increased length of DNA made by virions of murine leukemia virus at limiting magnesium ion concentration.
J. Virol.
21:168-178[Abstract/Free Full Text].
|
| 34.
|
Rothenberg, E.,
D. Smotkin,
D. Baltimore, and R. A. Weinberg.
1977.
In vitro synthesis of infectious DNA of murine leukaemia virus.
Nature
269:122-126[CrossRef][Medline].
|
| 35.
|
Schlegel, R.,
T. S. Tralka,
M. C. Willingham, and I. Pastan.
1983.
Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site?
Cell
32:639-646[CrossRef][Medline].
|
| 36.
|
Schlegel, R.,
M. C. Willingham, and I. H. Pastan.
1982.
Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells.
J. Virol.
43:871-875[Abstract/Free Full Text].
|
| 37.
|
Schloemer, R. H., and R. R. Wagner.
1975.
Mosquito cells infected with vesicular stomatitis virus yield unsialylated virions of low infectivity.
J. Virol.
15:1029-1032[Abstract/Free Full Text].
|
| 38.
|
Trono, D.
1992.
Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses.
J. Virol.
66:4893-4900[Abstract/Free Full Text].
|
| 39.
|
Verma, I. M.
1975.
Studies on reverse transcriptase of RNA tumor viruses. III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H.
J. Virol.
15:843-854[Abstract/Free Full Text].
|
| 40.
|
Wei, S. Q.,
K. Mizuuchi, and R. Craigie.
1998.
Footprints on the viral DNA ends in moloney murine leukemia virus preintegration complexes reflect a specific association with integrase.
Proc. Natl. Acad. Sci. USA
95:10535-10540[Abstract/Free Full Text].
|
| 41.
|
Whiting, S. H., and J. J. Champoux.
1998.
Properties of strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase: mechanistic implications.
J. Mol. Biol.
278:559-577[CrossRef][Medline].
|
| 42.
|
Wolgamot, G.,
J. E. J. Rasko, and A. D. Miller.
1998.
Retrovirus packaging cells expressing the Mus dunni endogenous virus envelope facilitate transduction of CHO and primary hematopoietic cells.
J. Virol.
72:10242-10245[Abstract/Free Full Text].
|
| 43.
|
Yoder, K. E., and F. D. Bushman.
2000.
Repair of gaps in retroviral DNA integration intermediates.
J. Virol.
74:11191-11200[Abstract/Free Full Text].
|
Journal of Virology, July 2001, p. 6375-6383, Vol. 75, No. 14
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.14.6375-6383.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Kines, K. J., Morales, M. E., Mann, V. H., Gobert, G. N., Brindley, P. J.
(2008). Integration of reporter transgenes into Schistosoma mansoni chromosomes mediated by pseudotyped murine leukemia virus. FASEB J.
22: 2936-2948
[Abstract]
[Full Text]
-
Coil, D. A., Miller, A. D.
(2005). Enhancement of Enveloped Virus Entry by Phosphatidylserine. J. Virol.
79: 11496-11500
[Abstract]
[Full Text]
-
Kolokoltsov, A. A., Weaver, S. C., Davey, R. A.
(2005). Efficient Functional Pseudotyping of Oncoretroviral and Lentiviral Vectors by Venezuelan Equine Encephalitis Virus Envelope Proteins. J. Virol.
79: 756-763
[Abstract]
[Full Text]
-
Coil, D. A., Miller, A. D.
(2004). Phosphatidylserine Is Not the Cell Surface Receptor for Vesicular Stomatitis Virus. J. Virol.
78: 10920-10926
[Abstract]
[Full Text]
-
Jones, K. S., Nath, M., Petrow-Sadowski, C., Baines, A. C., Dambach, M., Huang, Y., Ruscetti, F. W.
(2002). Similar Regulation of Cell Surface Human T-Cell Leukemia Virus Type 1 (HTLV-1) Surface Binding Proteins in Cells Highly and Poorly Transduced by HTLV-1-Pseudotyped Virions. J. Virol.
76: 12723-12734
[Abstract]
[Full Text]
-
Kang, Y., Stein, C. S., Heth, J. A., Sinn, P. L., Penisten, A. K., Staber, P. D., Ratliff, K. L., Shen, H., Barker, C. K., Martins, I., Sharkey, C. M., Sanders, D. A., McCray, P. B. Jr., Davidson, B. L.
(2002). In Vivo Gene Transfer Using a Nonprimate Lentiviral Vector Pseudotyped with Ross River Virus Glycoproteins. J. Virol.
76: 9378-9388
[Abstract]
[Full Text]